SCHEMBL2076700

SCHEMBL2076700

[CH2]N1CCC(c2ccccn2)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
SPR P35270 1/20 0.44
USP30 Q70CQ3 1/20 0.43
DRD4 P21917 5/20 0.43
KDM5A P29375 1/20 0.43
MAP4K4 O95819 1/20 0.41
PDCD1LG2 Q9BQ51 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
NAMPT P43490 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3580228 0.89 DRD4 (0.48) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL21274017 0.83 DRD4 (0.50) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL2076284 0.79 HSD11B1 (0.46) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL19087063 0.79 HSD11B1 (0.46) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL15025142 0.79 HSD11B1 (0.49) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL19117549 0.77 DRD4 (0.50) HSD11B1DRD4PDCD1LG2CD274DRD2
SCHEMBL3845634 0.77 DRD4 (0.50) HSD11B1DRD4PDCD1LG2CD274DRD2
SCHEMBL3104655 0.76 USP30 (0.52) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL2737376 0.76 KDM5A (0.48) HSD11B1CHRM2CHRM4CHRM5CHRM1
SCHEMBL171599 0.75 DRD4 (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293687-A1 Benzamide Compounds ASTRAZENECA AB (SE) 2008-11-27 US claimed
WO-2006024841-A2 BENZAMIDE COMPOUNDS ASTRAZENECA AB (SE) 2006-03-09 WO claimed
US-7897778-B2 Benzamide compounds ASTRAZENECA (SE) 2011-03-01 US disclosed
US-20080293687-A1 Benzamide Compounds ASTRAZENECA AB (SE) 2008-11-27 US disclosed
WO-2006024841-A2 BENZAMIDE COMPOUNDS ASTRAZENECA AB (SE) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293687-A1 Benzamide Compounds HDAC1, HDAC11, HDAC2 HSD11B1 2164/4885CHRM2 879/4885CHRM4 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.